Radio Frequency Ablation of Renal Cell Carcinoma: Preliminary Clinical Experience
2002; Lippincott Williams & Wilkins; Volume: 167; Issue: 5 Linguagem: Inglês
10.1016/s0022-5347(05)65062-8
ISSN1527-3792
AutoresThierry de Baère, Viseth Kuoch, Tarek Smayra, Clarisse Dromain, Tatiana Cabrera, B Court, Alain Roche,
Tópico(s)Hepatocellular Carcinoma Treatment and Prognosis
ResumoNo AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 May 2002Radio Frequency Ablation of Renal Cell Carcinoma: Preliminary Clinical Experience THIERRY de BAERE, VISETH KUOCH, TAREK SMAYRA, CLARISSE DROMAIN, TATIANA CABRERA, BERNARD COURT, and ALAIN ROCHE THIERRY de BAERETHIERRY de BAERE , VISETH KUOCHVISETH KUOCH , TAREK SMAYRATAREK SMAYRA , CLARISSE DROMAINCLARISSE DROMAIN , TATIANA CABRERATATIANA CABRERA , BERNARD COURTBERNARD COURT , and ALAIN ROCHEALAIN ROCHE View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)65062-8AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We assess the feasibility, safety and efficacy of radio frequency ablation of small peripheral renal cell carcinomas. Materials and Methods: Five patients with a histologically proven renal cell carcinoma 30 to 40 mm. in diameter were treated with radio frequency ablation. A triple needle electrode was percutaneously advanced into each tumor under sonographic (4 cases) or computerized tomography (CT) (1) guidance. The radio frequency generator was activated for 15 minutes in each location where the electrode had been placed. Patients were then followed with CT and blood tests every 2 months for 6 months and every 3 months thereafter. Results: Four tumors required 1 radio frequency delivery and 1 required 2 applications during the same session. No complications were encountered except for a subcapsular hematoma in 1 patient, which resolved spontaneously. Two patients experienced transient hematuria. Of the patients 4 were discharged from the hospital after 2 days and 1 after 1 day. After 6 to 18 months (median 9) all patients were tumor-free on CT without suppress additional treatment. Conclusions: In this small preliminary study radio frequency ablation of small peripheral renal cell carcinomas appears to be a feasible, safe and promising technique. References 1 : Rising incidence of renal cell cancer in the United States. JAMA1999; 281: 1628. Google Scholar 2 : Increased incidence of serendipitously discovered renal cell carcinoma. Urology1998; 51: 203. Google Scholar 3 : Increased incidental detection and reduced mortality in renal cancer—recent retrospective analysis at eight institutions. Int J Urol1995; 2: 77. Google Scholar 4 : Partial nephrectomy: alternative treatment for selected patients with renal cell carcinoma. Urology1998; 52: 584. Google Scholar 5 : Laparoscopic and percutaneous radiofrequency ablation of the kidney: acute and chronic porcine study. Urology2000; 56: 197. Google Scholar 6 : Laparoscopic extirpation of renal cell cancer: feasibility, questions, and concerns. Semin Surg Oncol1996; 12: 100. Google Scholar 7 : Nephron-sparing surgery for renal cell carcinoma. Br J Urol1998; 82: 321. Google Scholar 8 : Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg2000; 232: 381. Google Scholar 9 : Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol2000; 175: 1619. Google Scholar 10 : Radiofrequency ablation: an outpatient percutaneous treatment. Med Health R I1999; 82: 213. Google Scholar 11 : Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am1998; 80: 815. Google Scholar 12 : Radiofrequency thermal ablation of a splenic metastasis. J Vasc Interv Radiol2001; 12: 261. Google Scholar 13 : Assessing radiofrequency ablation of non-small cell cancer with positron emission tomography. Radiology2000; 217: 334. Google Scholar 14 : Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy: preliminary report of a new technology. Urology1999; 53: 465. Google Scholar 15 : Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol1997; 11: 251. Google Scholar 16 : Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology2000; 217: 665. Google Scholar 17 : Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor. AJR Am J Roentgenol2000; 174: 1592. Google Scholar 18 : Indications for conservative surgery in certain renal tumors: a study based on the growth pattern of the clear cell carcinoma. J Urol1950; 20: 1928. Google Scholar 19 : Efficacy of nephron sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol1999; 17: 1868. Google Scholar 20 : Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol2001; 177: 375. Google Scholar 21 : Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. RadioGraphics2000; 20: 9. Google Scholar 22 : Hepatic metastases: percutaneous radio-frequency ablation with cooled tip electrodes. Radiology1997; 205: 367. Google Scholar 23 : Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol2002; 178: 53. Google Scholar 24 : Microwave coagulation therapy with interruption of hepatic blood in- or outflow: an experimental study. J Vasc Interv Radiol2001; 12: 619. Google Scholar 25 : Intraductal cooling of the main bile ducts during intraoperative radiofrequency ablation. J Surg Oncol2001; 76: 297. Google Scholar From the Département d’Imagerie Médicale and Département de Chirurgie, Institut Gustave Roussy, Villejuif, France© 2002 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited ByNguyen C, Lane B, Kaouk J, Hegarty N, Gill I, Novick A and Campbell S (2018) Surgical Salvage of Renal Cell Carcinoma Recurrence After Thermal Ablative TherapyJournal of Urology, VOL. 180, NO. 1, (104-109), Online publication date: 1-Jul-2008.MABJEESH N, AVIDOR Y and MATZKIN H (2018) Emerging Nephron Sparing Treatments for Kidney Tumors: A Continuum of Modalities From Energy Ablation to Laparoscopic Partial NephrectomyJournal of Urology, VOL. 171, NO. 2, (553-560), Online publication date: 1-Feb-2004.HWANG J, WALTHER M, PAUTLER S, COLEMAN J, HVIZDA J, PETERSON J, LINEHAN W and WOOD B (2018) Radio Frequency Ablation of Small Renal Tumors: Intermediate ResultsJournal of Urology, VOL. 171, NO. 5, (1814-1818), Online publication date: 1-May-2004.JOHNSON D, TAYLOR G, LOTAN Y, SAGALOWSKY A, KOENEMANN K and CADEDDU J (2018) The Effects of Radio Frequency Ablation on Renal Function and Blood PressureJournal of Urology, VOL. 170, NO. 6, (2234-2236), Online publication date: 1-Dec-2003.MICHAELS M, RHEE H, MOURTZINOS A, SUMMERHAYES I, SILVERMAN M and LIBERTINO J (2018) Incomplete Renal Tumor Destruction Using Radio Frequency Interstitial AblationJournal of Urology, VOL. 168, NO. 6, (2406-2410), Online publication date: 1-Dec-2002. Volume 167Issue 5May 2002Page: 1961-1964 Advertisement Copyright & Permissions© 2002 by American Urological Association, Inc.Keywordstherapeuticscarcinoma, renal cellMetricsAuthor Information THIERRY de BAERE More articles by this author VISETH KUOCH More articles by this author TAREK SMAYRA More articles by this author CLARISSE DROMAIN More articles by this author TATIANA CABRERA More articles by this author BERNARD COURT More articles by this author ALAIN ROCHE More articles by this author Expand All Advertisement PDF DownloadLoading ...
Referência(s)